Umbilical cord blood stem cell transplant may help patients with lung, heart disordersNovember 24th, 2009 - 1:56 pm ICT by ANI
Washington, Nov 24 (ANI): Human-derived umbilical cord blood (UCB) stem cells transplanted in an animal model could help in developing therapies for specific lung and heart disorders, according to two separate studies.
For the studies, the researchers investigated the therapeutic benefits of transplanting human umbilical cord blood (UCB) mensenchymal stem cells (MSCs) into newborn laboratory rats with oxygen-deprived lung injury.
“Human UCB-derived MSCs (mesenchymal stem cells) have been successfully isolated, cultivated and been shown to differentiate into various cell types, such as osteoblasts, chondrocytes, adipocytes, stromal cells, skeletal cells, endothelial cells and neural cells and even lung-specific cells in vitro. It is not known, however, if human UCB-derived MSCs can differentiate into lung-specific cell types in vivo,” said co-author of the first study, Dr. Won Soon Park from the Samsung Medical Center, Seoul, Korea.
The researchers found that MSCs have a protective effect against hyperoxia-induced lung injury, likely due to anti-inflammatory effects.
They noted that their findings are expected to have important therapeutic potential for the currently untreatable hyperoxic neonatal lung disease, or bronchopulmonary dysplasia (BPD), in premature human infants.
The easy availability of UCB is an associated benefit.
Park noted that the optimal route for transplantation had not previously been determined.
“An injured lung produces soluble factors that cause MSCs to proliferate and migrate toward an injured lung. But it has been unclear if the local, intratracheal administration of MSCs is comparable to, or better than systemic transplantation,” he explained.
The researchers found that the intratracheal, rather than the intraperitoneal transplantation of human UCB-derived MSCs, significantly attenuated the hyperoxia-induced lung injury, such as decreased alveolarization and fibrosis.
However, survival rate was not improved by the MSC transplants.
It is still unclear if the donor cells exert a therapeutic effect by inducing direct tissue repair and regeneration of damaged cells, said the researchers.
The study has been published in the current issue of Cell Transplantation. (ANI)
- New study offers hope to those with Alzheimer's, ALS - Mar 08, 2011
- Umbilical cord cells may be useful in arthritis treatment - Nov 16, 2010
- Early umbilical cord clamping may interrupt 'nature's first stem cell transplant' - May 25, 2010
- Human umbilical cord blood cells accelerate diabetic wound healing - Feb 23, 2011
- Stem cells promising in post-injury arthritis - Aug 13, 2012
- Human neural stem cells 'can restore mobility in chronic spinal cord injury cases' - Aug 20, 2010
- Breast milk can be source for stem cells - Oct 18, 2011
- Human umbilical cord blood cells boost survival, maturation of key brain cells - Dec 15, 2010
- New hope for patients with end-stage liver disease - Jan 12, 2011
- Scientists create lung tissue from human embryonic stem cells - Nov 05, 2009
- Scientists focus on human cells for spinal cord injury repair - Mar 03, 2011
- Scientists develop toothy way to treat spinal injuries - Dec 04, 2011
- Scientists turn stem cells into intestinal tissue for the first time - Dec 13, 2010
- 'Smart' adult stem cells repair heart in 'landmark work' - Aug 17, 2010
- Boffins 'reprogram' adult mouse fat cells into stem cells - Jul 27, 2010
Tags: blood stem cell transplant, chondrocytes, cord blood stem cell, cord blood stem cell transplant, endothelial cells, heart disorders, human infants, human umbilical cord, laboratory rats, lung injury, mesenchymal stem cells, neural cells, optimal route, samsung medical center, seoul korea, skeletal cells, soluble factors, stem cell transplant, stromal cells, therapeutic benefits